Metrikler
Yayın
88
Açık Erişim
2
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
2001 - 2005
2001 - 2005Tıpta Uzmanlık
Atatürk Üniversitesi, Tıp Fakültesi, Türkiye
1988 - 1994
1988 - 1994Lisans
Necmettin Erbakan Üniversitesi, Meram Tıp Fakültesi, Türkiye
Araştırma Alanları
Tıp
Sağlık Bilimleri
Dahili Tıp Bilimleri
İç Hastalıkları
Onkoloji
Cerrahi Tıp Bilimleri
Genel Cerrahi
Cerrahi Onkoloji
Akademik Ünvanlar / Görevler
2005 - Devam Ediyor
2005 - Devam EdiyorDoktor
İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Onkoloji Enstitüsü
Makaleler
Tümü (69)
SCI-E, SSCI, AHCI (56)
SCI-E, SSCI, AHCI, ESCI (68)
ESCI (12)
Scopus (68)
TRDizin (10)
2025
20251. IGF Pathway Components as Potential Biomarkers in Gastric Cancer
CEYLANER B., ŞAHİN F., YILDIZ A., TAŞTEKİN D., GÖK A. F. K., BAYKAL A. T.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
, cilt.26, sa.22, 2025 (SCI-Expanded, Scopus)
2025
20252. A Pilot Study of Exploring miRNA-Protein Interaction Networks in Pancreatic Ductal Adenocarcinoma Patients: Implications for Diagnosis and Prognosis.
Şen S., Özgel M. Ç., Tunçer Ş. B., Bozbey H. U., Karabulut S., Taştekin D.
Diagnostics (Basel, Switzerland)
, cilt.15, sa.19, 2025 (SCI-Expanded)
2025
20253. Enhancing Antitumor Efficacy of MUC1 mRNA Nano-Vaccine by CTLA-4 siRNA-Mediated Immune Checkpoint Modulation in Triple Negative Breast Cancer Mice Model
Monfaredan A., Şen S., Fathi N. K., Taştekin D., Hosseininasab A., Bozbey H. U., et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
, cilt.26, sa.17, 2025 (SCI-Expanded)
2025
20254. Exosome Enveloped by Nano Lipid Particle a New Model for Signal Transducer and Activator of Transcription 3 Silencer Ribonucleic Acid Delivery System to a Glioblastoma Mice Model
Monfaredan A., ŞEN S., Hosseininasab A., TAŞTEKİN D., Fazli G., Bozbey H. U., et al.
Cancers
, cilt.17, sa.10, 2025 (SCI-Expanded, Scopus)
2024
20245. Comparison of efficacy and safety of 5-FU or capecitabine combined with cisplatin and docetaxel (mDCF and mDCX) as a first-line chemotherapy regimen in her 2-negative metastatic gastric cancer patients: A retrospective study
DEMİRCİ N. S., AZİZY A., Paksoy N., Doǧan I., KARABULUT S., Karahan L., et al.
Medicine (United States)
, cilt.103, sa.9, 2024 (SCI-Expanded)
2024
20246. Investigation of the potential of miRNA candidates as non-invasive biomarkers for the diagnosis and follow-up of colorectal cancer
KARABULUT S., ŞEN S., OĞUZ SOYDİNÇ H., Dogan I., TAŞTEKİN D., Karabulut M., et al.
PATHOLOGY RESEARCH AND PRACTICE
, cilt.254, 2024 (SCI-Expanded)
2024
20247. The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing
KÖSTEK O., Demirel A., Hacıoğlu M. B., TAŞTEKİN D., KARABULUT S., Gündogdu A., et al.
Journal of Chemotherapy
, cilt.36, sa.7, ss.613-621, 2024 (SCI-Expanded)
2023
20238. Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group
Ünal Ç., AZİZY A., KARABULUT S., TAŞTEKİN D., AKYILDIZ A., YAŞAR S., et al.
The oncologist
, cilt.28, sa.10, ss.875-884, 2023 (SCI-Expanded)
2023
20239. Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+rectal cancer: Istanbul R-02 phase II randomized study
Senyurek S., Saglam S., Saglam E. K., Yanar H., Gok K., TAŞTEKİN D., et al.
ONCOLOGY RESEARCH
, cilt.31, sa.5, ss.689-696, 2023 (SCI-Expanded)
2023
202310. Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first-line treatment of metastatic gastric cancer: A single-center experience
TAŞTEKİN D., Paksoy N., DOĞAN İ., Ferhatoglu F., KHANMAMMADOV N., Bozbey H. U., et al.
Journal of cancer research and therapeutics
, cilt.19, sa.2, ss.253-258, 2023 (SCI-Expanded)
2022
202211. Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group
Erol C., Nahit Sendur M. A., Bilgetekin I., Garbioglu D. B., Hamdard J., Akbas S., et al.
Journal of cancer research and therapeutics
, cilt.18, 2022 (SCI-Expanded)
2022
202212. Recent Advances in Immunotherapy in the Treatment of Gastrointestinal Tract Cancers
Karabulut S., Topalgokceli M. S., Tastekin D.
EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY
, cilt.6, sa.1, ss.12-15, 2022 (ESCI)
2022
202213. Quantification of cell-free circulating mitochondrial DNA copy number variation in hepatocellular carcinoma
Yalcinkaya B., Tastekin D., Guezelbulut F., Akgoz M., PENÇE S.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
, cilt.68, sa.9, ss.1161-1165, 2022 (SCI-Expanded)
2022
202214. Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study
Paksoy N., Ferhatoglu F., DOĞAN İ., Khanmammadov N., Bozbey H. U., KARABULUT S., et al.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
, cilt.37, sa.4, ss.478-483, 2022 (ESCI)
2021
202115. Does nutritional status affect treatment tolarability, response and survival in metastatic colorectal cancer patients? Results of a prospective multicenter study
Karabulut S., Dogan I., Usul Afsar C., Karabulut M., Karaman S., Ferhatoglu F., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.27, sa.6, ss.1357-1363, 2021 (SCI-Expanded)
2021
202116. WHAT'S NEW IN METASTATIC COLON CANCER TREATMENT?
Karabulut S., Karabulut M., Tastekin D.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, cilt.84, sa.3, ss.425-429, 2021 (ESCI)
2021
202117. Temozolomide and capecitabine (CAPTEM) is effective in metastatic well-differentiated gastrointestinal neuroendocrine tumors.
Dogan I., Tastekin D., Karabulut S., Sakar B.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.39, sa.3, 2021 (SCI-Expanded)
2021
202118. Role of mir-33a, mir-203b, mir361-3p, and mir-424 in hepatocellular carcinoma
Yalcinkaya B., Guzel Tanoglu E., Tastekin D., Pence S.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.51, sa.2, ss.638-643, 2021 (SCI-Expanded)
2020
202019. Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey
Hacioglu M. B., Kostek O., Karabulut S., Tastekin D., SEZGİN GÖKSU S., Alandag C., et al.
JOURNAL OF BUON
, cilt.25, sa.4, ss.1897-1903, 2020 (SCI-Expanded)
2019
201920. Investigation of JAM-A (rs790056) and LFA-1 (rs8058823) gene variants in Turkish colorectal cancer patients
Caykara B., Alsaadoni H., Pence H. H., Pence S., Aydogan H., Tastekin D.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.30, sa.10, ss.872-876, 2019 (SCI-Expanded)
2019
201921. The Association of Pancreatic Cancer and PALB2 Gene Mutations in the Turkish Population
Turkcan G. K., Odemis D., Avsar M., Tuncer S. B., Erciyas S., Erdogan Ö., et al.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
, cilt.34, sa.4, ss.283-290, 2019 (ESCI)
2019
201922. ROLE OF INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) AND INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 (IGFBP-3) IN THE DIAGNOSIS OF PANCREATIC ADENOCARCINOMA AND MONITORING TREATMENT RESPONSE
Bademler S., Ucuncu W. Z., Sari M., Yasasever C., Afsar C. U., Tastekin D.
ACTA MEDICA MEDITERRANEA
, cilt.35, sa.1, ss.71-75, 2019 (SCI-Expanded)
2018
201823. Evaluation of JAM-A (rs790056) and LFA-1 (rs8058823) Variants in Colorectal Cancer
Caykara B., Alsaadoni H., PENÇE H. H., Pence S., Aydogan H., Tastekin D.
ACTA PHYSIOLOGICA
, cilt.225, ss.25, 2018 (SCI-Expanded)
2018
201824. Neoadjuvant volumetric modulated arc therapy in rectal cancer and the correlation of pathological response with diffusion-weighted MRI and apoptotic markers.
Gurdal N., Fayda M., ALISHEV N., Bakir B., Tastekin D., Aykan F., et al.
Tumori
, cilt.104, ss.266-272, 2018 (SCI-Expanded)
2018
201825. Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)
Inal A., Kodaz H., Odabas H., Duran A. O., ŞEKER M. M., Inanc M., et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
, cilt.14, sa.3, ss.578-582, 2018 (SCI-Expanded)
2017
201726. Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection
Aydin D., Sendur M. A., KEFELİ U., Unal O. U., Tastekin D., Akyol M., et al.
CLINICAL COLORECTAL CANCER
, cilt.16, sa.3, ss.220-227, 2017 (SCI-Expanded)
2016
201627. Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology (ASMO)
Aydin D., Sendur M. A., KEFELİ U., Unal O. U., TAŞTEKİN D., Akyol M., et al.
JOURNAL OF BUON
, cilt.21, sa.5, ss.1242-1249, 2016 (SCI-Expanded)
2016
201628. Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients
Kiziltan H. S., TAŞTEKİN D., ERİŞ A. H., Taspinar O., Ismaylova M., MAYADAĞLI A.
BEZMIALEM SCIENCE
, cilt.4, sa.2, ss.51-55, 2016 (ESCI)
2016
201629. Clinical Significance of Serum Galectin-3 Levels in Gastric Cancer Patients.
Tas F., Bilgin E., Tastekın D., Erturk K., Duranyıldız D.
Journal of gastrointestinal cancer
, cilt.47, ss.182-6, 2016 (Scopus)
2016
201630. Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer
Tas F., Bilgin E., Tastekin D., Erturk K., Duranyildiz D.
BIOMEDICAL REPORTS
, cilt.4, sa.5, ss.609-614, 2016 (ESCI, Scopus)
2016
201631. Levels of serum fibronectin as a biomarker in gastric cancer patients: Correlation with clinical diagnosis and outcome
Tas F., Bılgın E., Karabulut S., Tastekın D., Duranyıldız D.
MOLECULAR AND CLINICAL ONCOLOGY
, cilt.4, sa.4, ss.655-659, 2016 (ESCI)
2016
201632. Clinical significance of serum protease-activated receptor-1 levels in gastric cancer patients
Tas F., Karabulut S., Tastekin D., Duranyildiz D.
BIOMEDICAL REPORTS
, cilt.4, sa.4, ss.489-492, 2016 (ESCI)
2016
201633. Clinical significance of serum laminin levels in patients with lung cancer
Tas F., Bilgin E., Tastekin D., Erturk K., Duranyildiz D.
BIOMEDICAL REPORTS
, cilt.4, sa.4, ss.485-488, 2016 (ESCI)
2016
201634. Is it solitary plasmacytoma or nonsecretory myeloma? A must-be-solved dilemma?
Erturk K., Tastekin D., Gundogdu G., Tas F., Vatansever S.
BIOMEDICINE & PHARMACOTHERAPY
, cilt.77, ss.27-29, 2016 (SCI-Expanded)
2016
201635. Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?
Erturk K., Tastekin D., Bilgin E., Serilmez M., Bozbey H. U., Sakar B.
BIOMEDICINE & PHARMACOTHERAPY
, cilt.77, ss.86-91, 2016 (SCI-Expanded, Scopus)
2016
201636. The relationship of beck depression inventory with vitamin D levels and visceral fat mass in cancer patients
Tuna S., Mert M., Soyluk O., Okuturlar Y., Kocoglu H., Tastekin D.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
, cilt.9, sa.5, ss.8719-8724, 2016 (SCI-Expanded)
2016
201637. Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer
Erturk K., Tastekin D., Serilmez M., Bilgin E., Bozbey H. U., Vatansever S.
TUMOR BIOLOGY
, cilt.37, sa.1, ss.405-412, 2016 (SCI-Expanded, Scopus)
2016
201638. Clinical significance of serum protease activated receptor1 levels in patients with lung cancer
Erturk K., Tastekin D., Bilgin E., Tas F., Disci R., Duranyildiz D.
European Review for Medical and Pharmacological Sciences
, cilt.20, sa.2, ss.243-249, 2016 (SCI-Expanded)
2015
201539. Bilateral Cystoid Macular Edema Secondary to Paclitaxel Treatment
Tezcan Y., Surmeli M., Tastekin D., Koc M.
ARCHIVES OF IRANIAN MEDICINE
, cilt.18, sa.9, ss.606-607, 2015 (SCI-Expanded)
2015
201540. Plasma homocysteine, folate and vitamin B12 levels in patients with lung cancer.
Tastekın D., Erturk K., Bozbey H. U., Olmuscelık O., Kızıltan H., Tuna S., et al.
Experimental oncology
, cilt.37, ss.218-22, 2015 (SCI-Expanded)
2015
201541. Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma
Turan N., Benekli M., Unal O. U., Unek I. T., Tastekin D., Dane F., et al.
CHINESE JOURNAL OF CANCER RESEARCH
, cilt.27, sa.4, ss.408-416, 2015 (SCI-Expanded)
2015
201542. Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer.
Tas F., Yasasever C. T., Karabulut S., Tastekin D., Duranyildiz D.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
, cilt.36, sa.3, ss.2097-103, 2015 (SCI-Expanded, Scopus)
2015
201543. Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancer
Arslan D., Tural D., Koca T., Tastekin D., Cerkesli A. K., Basaran H., et al.
JOURNAL OF BUON
, cilt.20, sa.2, ss.573-579, 2015 (SCI-Expanded)
2015
201544. Circulating annexin A2 as a biomarker in gastric cancer patients: Correlation with clinical variables
Tas F., Yasasever C. T., Karabulut S., Tastekin D., Duranyildiz D.
Biomedicine and Pharmacotherapy
, cilt.69, ss.237-241, 2015 (SCI-Expanded)
2015
201545. Radioprotectant and Cytotoxic Effects of Spirulina in Relapsed Verrucous Vulvar Cancer: A Case Report
KIZILTAN H. Ş., GÜNEŞ BAYIR A., Taspinar O., Yucesan G., Tastekin D., Sonmez F. C., et al.
ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE
, cilt.21, ss.68-72, 2015 (SCI-Expanded)
2015
201546. The Effects of Topical Insulin Application on Wound Healing
Kargin S., Tastekin D., Kilic K., Cezik A., Cakir M., Kucukkartallar T., et al.
EUROPEAN JOURNAL OF GENERAL MEDICINE
, cilt.12, sa.4, ss.302-306, 2015 (ESCI)
2015
201547. Progesterone receptor status in determining the prognosis of estrogen receptor positive/HER2 negative breast carcinoma patients
Bal O., Arslan U. Y., Durnali A., Uyetrk U., Demirci A., Tastekin D., et al.
JOURNAL OF BUON
, cilt.20, sa.1, ss.28-34, 2015 (SCI-Expanded)
2015
201548. Alpha-fetoprotein (AFP) elevation gastric adenocarcinoma and importance of AFP change in tumor response evaluation
Tatli A. M., Urakci Z., Kalender M. E., Arslan H., TAŞTEKİN D., Kaplan M. A.
Asian Pacific Journal of Cancer Prevention
, cilt.16, sa.5, ss.2003-2007, 2015 (SCI-Expanded)
2014
201449. The efficacy of Pistacia Terebinthus soap in the treatment of cetuximab-induced skin toxicity
Tastekin D., Tambas M., KILIC K., Erturk K., ARSLAN D.
INVESTIGATIONAL NEW DRUGS
, cilt.32, sa.6, ss.1295-1300, 2014 (SCI-Expanded)
2014
201450. Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients
Tastekin D., Kargin S., KARABULUT M., Yaldiz N., Tambas M., Gurdal N., et al.
TUMOR BIOLOGY
, cilt.35, sa.12, ss.11871-11877, 2014 (SCI-Expanded)
2014
201451. Clinical significance of serum fibronectin and vitronectin levels in melanoma patients
Tas F., Karabulut S., Bilgin E., Tastekin D., Duranyildiz D.
MELANOMA RESEARCH
, cilt.24, sa.5, ss.475-479, 2014 (SCI-Expanded)
2014
201452. Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer
Tas F., Karabulut S., Bilgin E., Tastekin D., Duranyildiz D.
TUMOR BIOLOGY
, cilt.35, sa.9, ss.9303-9309, 2014 (SCI-Expanded)
2014
201453. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.
TURAN N., Benekli M., DANE F., Unal O. U., Kara H. V., KOCA D., et al.
Thoracic cancer
, cilt.5, sa.5, ss.398-404, 2014 (SCI-Expanded)
2014
201454. The diagnostic, predictive, and prognostic role of serum epithelial cell adhesion molecule (EpCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in breast cancer
Karabulut S., Tas F., Tastekin D., KARABULUT M., Yasasever C., Ciftci R., et al.
TUMOR BIOLOGY
, cilt.35, sa.9, ss.8849-8860, 2014 (SCI-Expanded, Scopus)
2014
201455. Clinical significance of serum tenascin-C levels in breast cancer
Tastekin D., Tas F., Karabulut S., Duranyildiz D., Serilmez M., Guveli M., et al.
TUMOR BIOLOGY
, cilt.35, sa.7, ss.6619-6625, 2014 (SCI-Expanded, Scopus)
2014
201456. Clinical significance of serum tenascin-c levels in epithelial ovarian cancer
Didem T., Faruk T., Senem K., Derya D., Murat S., Murat G., et al.
TUMOR BIOLOGY
, cilt.35, sa.7, ss.6777-6782, 2014 (SCI-Expanded)
2014
201457. Assessment of tumor characteristics and factors affecting survival in patients with primary metastatic breast carcinoma: a Multicenter Study of the Anatolian Society of Medical Oncology
Uyeturk U., Oksuzoglu B., Akman T., Turker I., Sener N., Tastekin D., et al.
MEDICAL ONCOLOGY
, cilt.31, sa.4, 2014 (SCI-Expanded)
2014
201458. Impact of Poster Presentations on Academic Knowledge Transfer from the Oncologist Perspective in Turkey
Arslan D., Koca T., Tastekin D., Basaran H., Bozcuk H.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.15, sa.18, ss.7707-7711, 2014 (SCI-Expanded)
2014
201459. Outcome of Daily Cisplatin with Thoracic Chemoradiotherapy in Advanced Non-small Cell Lung Cancer Patients with Comorbid Disorders: a Pilot Study
KIZILTAN H. Ş., Bayir A. G., Tastekin D., ÇOBAN G., Eris A. H., AYDIN T., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.15, sa.20, ss.8591-8594, 2014 (SCI-Expanded)
2014
201460. Clinicopathologic Features and Molecular Subtypes of Breast Cancer in Young Women (Age <= 35)
Goksu S. S., Tastekin D., Arslan D., Gunduz S., TATLI A. M., Unal D., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.15, sa.16, ss.6665-6668, 2014 (SCI-Expanded)
2014
201461. Treatment modalities in primary gastric lymphoma: the effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology
Mehmet K., Sener C., Uyeturk U., Seker M., Tastekin D., Tonyali O., et al.
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY
, cilt.18, sa.4, ss.273-278, 2014 (ESCI)
2013
201362. Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma
Tas F., Karabulut S., Bilgin E., Sen F., Yildiz I., Tastekin D., et al.
TUMOR BIOLOGY
, cilt.34, sa.6, ss.3529-3536, 2013 (SCI-Expanded)
2013
201363. Rectal cancer in pregnancy: a case report and review of the literature.
Dogan N., Tastekin D., Kerimoglu O., Pekin A., Celik C.
Journal of gastrointestinal cancer
, cilt.44, ss.354-6, 2013 (SCI-Expanded)
2013
201364. Efficiency and Side Effects of Sorafenib Therapy for Advanced Hepatocellular Carcinoma: A Retrospective Study by the Anatolian Society of Medical Oncology
Berk V., Kaplan M. A., Tonyali O., Buyukberber S., Balakan O., ÖZKAN M., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.14, sa.12, ss.7367-7369, 2013 (SCI-Expanded)
2010
201065. The biochemical effectiveness of N-acetylcysteine in experimental spinal cord injury in rats.
Hanci V., Kerimoğlu A., Koca K., Başkesen A., Kiliç K., Taştekin D.
Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES
, cilt.16, ss.15-21, 2010 (SCI-Expanded)
2009
200966. [The opinions of Turkish physicians about the tasks of tuberculosis central dispensary].
Tanrikulu A., Palanci Y., Eren D., Yilmaz G., Karaca M., Abakay A., et al.
Tuberkuloz ve toraks
, cilt.57, ss.32-7, 2009 (ESCI)
2008
200867. Correlation between the erythrocyte sedimentation rate and blood nitric oxide levels in rabbits?
Uzun M., Saral S., Atakisi O., Yapar K., Uzlu E., Citil M., et al.
Scandinavian Journal of Laboratory Animal Science
, cilt.35, sa.1, ss.53-56, 2008 (SCI-Expanded)
2008
200868. Investigation of free radical scavenging enzyme activities and lipid peroxidation in liver tissue of zinc deficient rats
Kaya H., Taysi S., Kaya A., Boyuk A., DURSUN H., Islamoglu Y., et al.
Asian Journal of Chemistry
, cilt.20, sa.2, ss.1068-1074, 2008 (SCI-Expanded)
2006
200669. Hypoglycaemic effect of Artemisia herba-alba in experimental hyperglycaemic rats
Taştekin D., ATASEVER M., Adigüzel G., Keleş M., Taştekin A.
Bulletin of the Veterinary Institute in Pulawy
, cilt.50, sa.2, ss.235-238, 2006 (SCI-Expanded)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2023
20231. PANKREAS KANSERLİ HASTALARIN PERiFERİK KANINDA EPS8 VE KANK1 GEN EKSPRESYONLARININ İNCELENMESİ
ÖZGEL M. Ç., AKDENİZ ÖDEMİŞ D., TUNÇER Ş. B., TAŞTEKİN D., YAZICI H.
9. uluslararası beslenme obezite ve toplum sağlığı kongresi, 28 - 29 Ekim 2023, (Özet Bildiri)
2020
20202. Trastuzumab-based treatment of HER2-positive metastatic gastric cancer
Dogan I., Karabulut S., Tastekin D., Paksoy N., Sakar B., Vatansever S.
ESMO 22nd World Congress on Gastrointestinal Cancer, ELECTR NETWORK, 1 - 04 Temmuz 2020, cilt.31
2020
20203. The frequencies and prognostic significance of ABO blood and rhesus (D) groups in HER2-positive gastric cancer
Dogan I., Gurbuz M., Aydin E., Tastekin D., Karabulut S., Utkan G.
ESMO 22nd World Congress on Gastrointestinal Cancer, ELECTR NETWORK, 1 - 04 Temmuz 2020, cilt.31, (Özet Bildiri)
2020
20204. Does nutritional status affect treatment tolarability, response, and survival in metastatic colorectal cancer patients? Results of prospective multicenter study
Karabulut S., Dogan I., Afsar C. U., Karabulut M., Karaman S., Ferhatoglu F., et al.
Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology, San-Francisco, Kostarika, 23 - 25 Ocak 2020, cilt.38, (Özet Bildiri)
2016
20165. Mide Kanserinde Serum Interleukin-29, Interleukin-32 ve Tumor Necrosis Factor Alpha'nın Klinik Önemi
ERTÜRK K., TAŞTEKİN D., SERİLMEZ M., BİLGİN DOĞRU E., H. U., VATANSEVER S.
3. Ulusal İmmüno-Onkoloji ve Hedefe Yönelik Kanser Tedavileri Kongresi, Antalya, Türkiye, 11 - 15 Mayıs 2016, ss.1, (Tam Metin Bildiri)
2016
20166. Rektum kanserinde neoadj. sib-vmat yanıtının difüzyon MR ve serum apoptoz marker düzeyleri ile değerlendirilmesi
GÜRDAL N., FAYDA E. M., BAKIR B., Alishev N., GEZER U., TAŞTEKİN D., et al.
12. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 20 - 24 Nisan 2016, ss.45, (Tam Metin Bildiri)
2015
20157. Nüks meme kanserinde reoperatif sentinel lenf nodu biyopsisi: Aksilla korunabilir mi?
Karanlık H., Özgür İ., Kılıç B., Şanlı Y., Önder S., Taştekin D., et al.
13. Ulusal Meme Hastalıkları Kongresi, 2015, Antalya, Türkiye, 21 - 25 Ekim 2015, ss.1, (Özet Bildiri)
2015
20158. The role of adhesion molecules in hepatocellulary carcinoma
Tastekin D., DIKILITAS M., HARPUTLUOGLU H., Erturk K., CELEBI K., Sen F., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2015
20159. The prognostic value of lymph node ratio in patients with curatively resected pancreatic adenocarcinoma.
Turan N., Araz M., Algin E., Unal O. U., Benekli M., Tastekin D., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2014
201410. Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.
CIFTCI R., Tas F., AKSIT E., Vatansever S., KARABULUT S., Sen F., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)
2014
201411. Clinical significance of serum epithelial cell adhesion molecule (EPCAM) cud vascular cell adhesion molecule-1 (VCAM-1) levels in lung cancer.
KARABULUT S., Tastekin D., CIFTCI R., Tambas M., DAGOGLU N., Guveil M. E., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)
2014
201412. Clinical significance of serum caveolin-1 levels in melanoma.
Tastekin D., KARABULUT S., DURANYILDIZ D., Tas F.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)
2013
201313. Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma
Ciftci R., Karabulut S., Tastekin D., Sen F., Kilic L., Yildiz I., et al.
European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Hollanda, 27 Eylül - 01 Ekim 2013, cilt.49, (Özet Bildiri)
2013
201314. The effects of variability of mean erythrocyte corpuscular volume (MCV) in patients with advanced stage gastrointestinal stromal tumor (GIST) using imatinib on progression free survival
Cetin B., TAŞTEKİN D., Aktas B., Guler T., Kaplan M. A., Berk V., et al.
European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Hollanda, 27 Eylül - 01 Ekim 2013, cilt.49, (Özet Bildiri)
2013
201315. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.
Turan N., Dane F., Unal O. U., Benekli M., Kara H. V., Koca D., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2013
201316. Coagulation assays in breast cancer: Correlation of plasma D-dimer with tumor load and invasiveness in breast cancer patients.
Karabulut S., Kilic L., Ciftci R., Yildiz I., Sen F., Keskin S., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2013
201317. Comparison of mucosal and cutaneous melanoma in the head and neck region: Different clinical features and similar outcomes.
Ciftci R., Keskin S., Karabulut S., Yildiz I., Kilic L., Sen F., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
Kitaplar
2024
20241. High-Dose Vitamin C Is an Unorthodox Approach to Cancer Treatment
Şen S., Ugar M., Bozbey H. U., Taştekin D.
Original Research and Reviews in the Field of Medical Oncology, selim güngör, Editör, Platanus Publishing, Ankara, ss.5-44, 2024
2024
20242. The Role of Extracellular Vesicles in Drug Resistance and Treatment of Metastatic Cancers
Şen S., Taştekin D.
Original Research and Reviews in the Field of Medical Oncology, Selim Güngör, Editör, Platanus Publishing, Ankara, ss.45-72, 2024
Desteklenen Projeler
2020 - 2021
2020 - 2021
RECITE: Gastrointestinal veya Kolorektal Kanserin Tedavisi için FOLFOX bazlı Kemoterapi Alan Hastalarda Kemoterapiye Bağlı Trombositopeninin Tedavisinde Romiplostimi Değerlendiren Faz 3, Randomize Plasebo Kontrollü Çift Kör Çalışma
Diğer Özel Kurumlarca Desteklenen Proje
Taştekin D. (Yürütücü)
2016 - 2018
2016 - 2018
Mide Kanserli Hastalarda miRNA Seviyelerinin Belirlenmesi
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
BADEMLER S. (Yürütücü), HOSNI SOBHI ALSAADONI H., PENÇE S., ŞABANÇELEBİ S.
2016 - 2018
2016 - 2018
Kolon Kanseri Hastalarında MACC1 FİLAMİN A VE FBXW7 Genlerinin Ekspresyon Seviyelerinin İncelenmesi
Yükseköğretim Kurumları Destekli Proje , BAP Y.Lisans
ERGEN H. A. (Yürütücü), HOSNI SOBHI ALSAADONI H., TAŞTEKİN D., YEŞİLKAYA F.
2015 - 2017
2015 - 2017